XML 38 R16.htm IDEA: XBRL DOCUMENT v3.8.0.1
Financial Instruments
12 Months Ended
Dec. 31, 2017
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Financial instruments
FINANCIAL INSTRUMENTS

The Company’s financial instruments include cash and marketable securities. Due to the short-term nature of these instruments, their book value approximates their fair value. The Company’s financial instruments may include long-term debt, interest rate and cross-currency swaps, commodity derivative contracts and foreign currency derivatives. All derivative contracts are placed with counterparties that have an S&P, or equivalent, investment grade credit rating at the time of the contracts’ placement. At December 31, 2017 and 2016, the Company had no derivative contracts that contained credit risk related contingent features.

The Company uses certain commodity derivative contracts to protect against commodity price changes related to forecasted raw material and supplies purchases. The Company primarily utilizes forward and option contracts, which are designated as cash flow hedges. At December 31, 2017, there were no commodity derivative contracts outstanding:
 
Commodity derivative contracts
Commodity
Volume hedged December 31, 2017
 
Volume hedged December 31, 2016
 
Units of measure
 
Duration
Copper

 
213.8

 
Metric Tons
 



The Company manages its interest rate risk by balancing its exposure to fixed and variable rates while attempting to optimize its interest costs. The Company selectively uses interest rate swaps to reduce market value risk associated with changes in interest rates (fair value hedges). At December 31, 2017 and December 31, 2016, the Company had no outstanding interest rate swaps.

The Company uses foreign currency forward and option contracts to protect against exchange rate movements for forecasted cash flows, including capital expenditures, purchases, operating expenses or sales transactions designated in currencies other than the functional currency of the operating unit. In addition, the Company uses foreign currency forward contracts to hedge exposure associated with our net investment in certain foreign operations (net investment hedges). The Company has also designated its Euro denominated debt as a net investment hedge of the Company's investment in a European subsidiary. Foreign currency derivative contracts require the Company, at a future date, to either buy or sell foreign currency in exchange for the operating units’ local currency. At December 31, 2017 and December 31, 2016, the following foreign currency derivative contracts were outstanding:
Foreign currency derivatives (in millions)
Functional currency
 
Traded currency
 
Notional in traded currency
December 31, 2017
 
Notional in traded currency
December 31, 2016
 
Ending Duration
Brazilian real
 
Euro
 
1.1

 

 
Apr - 18
Chinese renminbi
 
Euro
 
18.6

 

 
Jun - 18
Chinese renminbi
 
US dollar
 
36.0

 
33.5

 
Sept - 18
Euro
 
British pound
 
3.9

 
4.2

 
Dec - 18
Euro
 
Chinese renminbi
 
85.0

 

 
Dec - 18
Euro
 
Japanese yen
 
1,311.3

 
1,004.8

 
Dec - 18
Euro
 
Polish zloty
 

 
18.8

 
Dec - 17
Euro
 
Swedish krona
 
267.4

 

 
May - 18
Euro
 
US dollar
 
56.5

 
35.3

 
Mar - 19
Japanese yen
 
Chinese renminbi
 

 
68.7

 
Dec - 17
Japanese yen
 
Korean won
 

 
5,689.2

 
Dec - 17
Japanese yen
 
US dollar
 

 
2.0

 
Dec - 17
Korean won
 
Euro
 
3.1

 

 
Dec - 18
Korean won
 
Japanese yen
 
619.0

 
539.9

 
Dec - 18
Korean won
 
US dollar
 
11.2

 
14.2

 
Dec - 18
Mexican peso
 
US dollar
 

 
10.5

 
Dec - 17
Swedish krona
 
Euro
 
109.7

 
48.2

 
Jan - 20
US dollar
 
Euro
 
42.0

 

 
Dec - 18


At December 31, 2017 and 2016, the following amounts were recorded in the Consolidated Balance Sheets as being payable to or receivable from counterparties under ASC Topic 815:
 
Assets
 
Liabilities
(millions of dollars)
Location
 
December 31, 2017
 
December 31, 2016
 
Location
 
December 31, 2017
 
December 31, 2016
Foreign currency
Prepayments and other current assets
 
$
0.9

 
$
7.2

 
Accounts payable and accrued expenses
 
$
5.0

 
$
1.1

 
Other non-current assets
 
$
0.8

 
$

 
Other non-current liabilities
 
$

 
$

Commodity
Prepayments and other current assets
 
$

 
$
0.1

 
Accounts payable and accrued expenses
 
$

 
$



Effectiveness for cash flow and net investment hedges is assessed at the inception of the hedging relationship and quarterly, thereafter. To the extent that derivative instruments are deemed to be effective, gains and losses arising from these contracts are deferred into accumulated other comprehensive income (loss) ("AOCI") and reclassified into income as the underlying operating transactions are recognized. These realized gains or losses offset the hedged transaction and are recorded on the same line in the statement of operations. To the extent that derivative instruments are deemed to be ineffective, gains or losses are recognized into income.

The table below shows deferred gains (losses) reported in AOCI, as well as the amount expected to be reclassified to income in one year or less. The amount expected to be reclassified to income in one year or less assumes no change in the current relationship of the hedged item at December 31, 2017 market rates.
 
 
Deferred gain (loss) in AOCI at
 
Gain (loss) expected to be reclassified to income in one year or less
(millions of dollars)
 
December 31, 2017
 
December 31, 2016
 
Foreign currency
 
$
(2.3
)
 
$
5.6

 
$
(3.1
)
Commodity
 

 
(0.1
)
 

Net investment hedges
 
(54.2
)
 
29.5

 

Total
 
$
(56.5
)
 
$
35.0

 
$
(3.1
)


Derivative instruments designated as hedging instruments as defined by ASC Topic 815 held during the period resulted in the following gains and losses recorded in income:
 
 
 
 
Gain (loss) reclassified from AOCI to income
(effective portion)
 
 
 
Gain (loss) recognized in income
(ineffective portion)
 
 
 
 
Year Ended December 31,
 
 
 
Year Ended December 31,
(millions of dollars)
 
Location
 
2017
 
2016
 
Location
 
2017
 
2016
Foreign currency
 
Sales
 
$
3.4

 
$
(0.1
)
 
SG&A expense
 
$

 
$
0.3

Foreign currency
 
Cost of goods sold
 
$
(0.1
)
 
$
1.4

 
SG&A expense
 
$
(0.1
)
 
$

Commodity
 
Cost of goods sold
 
$
0.5

 
$
(1.4
)
 
Cost of goods sold
 
$

 
$
(0.3
)


 
 
 
 
Year Ended December 31,
(millions of dollars)
 
 
 
2017
 
2016
Contract Type
 
Location
 
Gain (loss) on swaps
 
Gain (loss) on borrowings
 
Gain (loss) on swaps
 
Gain (loss) on borrowings
Interest rate swap
 
Interest expense and finance charges
 
$

 
$

 
$
8.5

 
$
(8.5
)


At December 31, 2017 and 2016, derivative instruments that were not designated as hedging instruments as defined by ASC Topic 815 were immaterial.